| pubmed-article:12045366 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0020473 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0037473 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0205081 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0443288 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:12045366 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:12045366 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12045366 | pubmed:dateCreated | 2002-6-4 | lld:pubmed |
| pubmed-article:12045366 | pubmed:abstractText | The effect of dietary sodium restriction on insulin, lipids, and blood pressure has been controversial. Evidence suggests that adverse short-term effects in response to very low-salt diets do not persist long-term with modest sodium restriction. In this study, the effects of modest dietary sodium restriction (60 and 120 mmol sodium) were measured for 3 weeks in 12 lean normotensives and 10 obese hypertensives. Blood pressure, plasma lipids, and the pressor response to an infusion of Intralipid and heparin were obtained. In contrast to previous reports concerning very low-salt diets, obese hypertensives did not manifest a pressor response or an adverse lipid effect with moderate salt restriction. Obese hypertensives were not more salt-sensitive than lean normotensives and did not manifest a different hemodynamic response to 4-hour infusion of Intralipid and heparin while on the 120-mmol/day salt diet. During the 60-mmol/day salt diet, however, plasma triglycerides increased more in obese than in lean volunteers during the Intralipid and heparin infusion (398+/-38 vs. 264+/-18 mg/dL; p<0.05), and there were greater increases in mean blood pressure (12+/-2 vs. 7+/-2 mm Hg; p<0.05) and systemic vascular resistance (111+/-38 vs. 225+/-44 dyne.sec.cm-5) as well as a larger decrease in small artery compliance (22.5+/-0.6 vs. 20.4+/-0.6 mL/mm Hg x 100; p<0.05). These data suggest that modest dietary sodium restriction in obese hypertensives does not adversely affect baseline blood pressure or lipids, but it does magnify their adverse lipid and hemodynamic response to fat loading. | lld:pubmed |
| pubmed-article:12045366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12045366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12045366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12045366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12045366 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12045366 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12045366 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12045366 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12045366 | pubmed:issn | 1524-6175 | lld:pubmed |
| pubmed-article:12045366 | pubmed:author | pubmed-author:GoodfriendT... | lld:pubmed |
| pubmed-article:12045366 | pubmed:author | pubmed-author:ZhangDD | lld:pubmed |
| pubmed-article:12045366 | pubmed:author | pubmed-author:EwerT KTK | lld:pubmed |
| pubmed-article:12045366 | pubmed:author | pubmed-author:LopesH FHF | lld:pubmed |
| pubmed-article:12045366 | pubmed:author | pubmed-author:StojiljkovicM... | lld:pubmed |
| pubmed-article:12045366 | pubmed:copyrightInfo | Copyright 2002 Le Jacq Communications, Inc. | lld:pubmed |
| pubmed-article:12045366 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12045366 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:12045366 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12045366 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12045366 | pubmed:pagination | 173-80 | lld:pubmed |
| pubmed-article:12045366 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:meshHeading | pubmed-meshheading:12045366... | lld:pubmed |
| pubmed-article:12045366 | pubmed:articleTitle | Moderate sodium restriction enhances the pressor response to hyperlipidemia in obese, hypertensive patients. | lld:pubmed |
| pubmed-article:12045366 | pubmed:affiliation | Department of Pharmacology, Medical University of South Carolina, Charleston, SC 29425, USA. | lld:pubmed |
| pubmed-article:12045366 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12045366 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12045366 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12045366 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
